{"nctId":"NCT03992846","briefTitle":"Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.","startDateStruct":{"date":"2019-06-13","type":"ACTUAL"},"conditions":["Endometriosis"],"count":486,"armGroups":[{"label":"Linzagolix 75 mg","type":"EXPERIMENTAL","interventionNames":["Drug: 75 mg linzagolix tablet","Drug: Placebo tablet to match 200 mg linzagolix tablet","Drug: Placebo capsule to match Add-back capsule"]},{"label":"Linzagolix 200 mg + Add-back (E2 1 mg / NETA 0.5 mg)","type":"EXPERIMENTAL","interventionNames":["Drug: 200 mg linzagolix tablet","Drug: Add-back capsule (E2 1 mg / NETA 0.5 mg)","Drug: Placebo tablet to match 75 mg linzagolix tablet"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo tablet to match 75 mg linzagolix tablet","Drug: Placebo tablet to match 200 mg linzagolix tablet","Drug: Placebo capsule to match Add-back capsule"]}],"interventions":[{"name":"75 mg linzagolix tablet","otherNames":[]},{"name":"200 mg linzagolix tablet","otherNames":[]},{"name":"Add-back capsule (E2 1 mg / NETA 0.5 mg)","otherNames":[]},{"name":"Placebo tablet to match 75 mg linzagolix tablet","otherNames":[]},{"name":"Placebo tablet to match 200 mg linzagolix tablet","otherNames":[]},{"name":"Placebo capsule to match Add-back capsule","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nThe subject must have:\n\n* Her most recent surgical and - if available - histological diagnosis of pelvic endometriosis up to 10 years before screening.\n* Moderate to severe endometriosis-associated pain during the screening period.\n* Regular menstrual cycles.\n* BMI â‰¥ 18 kg/m2 at the screening visit. -\n\nExclusion Criteria:\n\nThe subject will be excluded if she:\n\n* Is pregnant or breast feeding or is planning a pregnancy within the duration of the treatment period of the study.\n* Is less than 6 months postpartum or 3 months postabortion/ miscarriage at the time of entry into the screening period.\n* Has had a surgical history of any major abdominal surgery within 6 months or any interventional surgery for endometriosis performed within a period of 2 months before screening.\n* Did not respond to prior treatment with GnRH agonists or GnRH antagonists for endometriosis.\n* Has a history of, or known, osteoporosis or other metabolic bone disease.\n* Has chronic pelvic pain that is not caused by endometriosis and requires chronic analgesic or other chronic therapy which would interfere with the assessment of endometriosis-associated pain.","healthyVolunteers":false,"sex":"FEMALE","genderBased":true,"genderDescription":"Females Only","minimumAge":"18 Years","maximumAge":"49 Years","stdAges":["ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Reduction of Dysmenorrhea (DYS) at Month 3 - Proportion of Responders","description":"Percentage of subjects with reduction of 1.1 for DYS in mean pelvic pain score within last 28 days prior to Month 3 or discontinuation, and stable or decreased use of analgesics for Endometriosis-associated pain (=EAP) within the same calendar days.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44.0","spread":null},{"groupId":"OG001","value":"72.9","spread":null},{"groupId":"OG002","value":"23.5","spread":null}]}]}]},{"type":"PRIMARY","title":"Reduction of Non-menstrual Pelvic Pain (NMPP) at Month 3 - Proportion of Responders","description":"Percentage of subjects with reduction of 0.8 for NMPP in mean pelvic pain score within last 28 days prior to Month 3 or discontinuation, and stable or decreased use of analgesics for Endometriosis-associated pain (=EAP) within the same calendar days.","paramType":"NUMBER","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.9","spread":null},{"groupId":"OG001","value":"47.3","spread":null},{"groupId":"OG002","value":"30.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":160},"commonTop":["Headache","Hot flush","Fatigue","Anaemia","Nausea"]}}}